THRASOS THERAPEUTICS INC has a total of 19 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2005. It filed its patents most often in WIPO (World Intellectual Property Organization), Japan and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are PALINGEN INC, LEUKOLECT AS and PROMEDIOR INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | Japan | 4 | |
#3 | United States | 4 | |
#4 | Australia | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Computer technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Analysing materials | |
#5 | Bioinformatics |
# | Name | Total Patents |
---|---|---|
#1 | Bosukonda Dattatreymurty | 11 |
#2 | Sworin Michael | 10 |
#3 | Keck Peter C | 9 |
#4 | Carlson William D | 9 |
#5 | Leger Roger | 6 |
#6 | Rossert Jerome | 6 |
#7 | Dube Gilles | 4 |
#8 | Caruso Marie Elaine | 3 |
#9 | Keck Peter | 2 |
#10 | Peter C Keck | 1 |
Publication | Filing date | Title |
---|---|---|
WO2018035617A1 | Antibiotic carrier conjugates for the treatment of kidney infections | |
WO2018035615A1 | Compositions and methods for the treatment of inflammatory bowel diseases | |
US9611297B1 | Compositions and methods for the treatment of cast nephropathy and related conditions | |
WO2017011917A1 | Methods for treating and preventing polycystic kidney diseases (pkd) using amp-activated protein kinase (ampk) modulators and activators | |
AU2012201060A1 | TDF-related compounds and analogs thereof | |
AU2012200042A1 | TDF-related compounds and analogs thereof |